The world of extracorporeal technologies is rapidly expanding. In particular, we are trying to make cardiopulmonary bypass (CPB) more physiological for end-organ protection by reducing complications related to biocompatibility, inflammation, hemodilution, coagulation management, and gaseous micro-embolic activity. The literature describes various extracorporeal techniques that seek to eliminate air-blood contact and reduce hemodilution and the contact…